These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21862999)

  • 1. Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy.
    Deichmann A; Brugman MH; Bartholomae CC; Schwarzwaelder K; Verstegen MM; Howe SJ; Arens A; Ott MG; Hoelzer D; Seger R; Grez M; Hacein-Bey-Abina S; Cavazzana-Calvo M; Fischer A; Paruzynski A; Gabriel R; Glimm H; Abel U; Cattoglio C; Mavilio F; Cassani B; Aiuti A; Dunbar CE; Baum C; Gaspar HB; Thrasher AJ; von Kalle C; Schmidt M; Wagemaker G
    Mol Ther; 2011 Nov; 19(11):2031-9. PubMed ID: 21862999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.
    Deichmann A; Hacein-Bey-Abina S; Schmidt M; Garrigue A; Brugman MH; Hu J; Glimm H; Gyapay G; Prum B; Fraser CC; Fischer N; Schwarzwaelder K; Siegler ML; de Ridder D; Pike-Overzet K; Howe SJ; Thrasher AJ; Wagemaker G; Abel U; Staal FJ; Delabesse E; Villeval JL; Aronow B; Hue C; Prinz C; Wissler M; Klanke C; Weissenbach J; Alexander I; Fischer A; von Kalle C; Cavazzana-Calvo M
    J Clin Invest; 2007 Aug; 117(8):2225-32. PubMed ID: 17671652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.
    Schwarzwaelder K; Howe SJ; Schmidt M; Brugman MH; Deichmann A; Glimm H; Schmidt S; Prinz C; Wissler M; King DJ; Zhang F; Parsley KL; Gilmour KC; Sinclair J; Bayford J; Peraj R; Pike-Overzet K; Staal FJ; de Ridder D; Kinnon C; Abel U; Wagemaker G; Gaspar HB; Thrasher AJ; von Kalle C
    J Clin Invest; 2007 Aug; 117(8):2241-9. PubMed ID: 17671654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
    Cavazzana M; Six E; Lagresle-Peyrou C; André-Schmutz I; Hacein-Bey-Abina S
    Hum Gene Ther; 2016 Feb; 27(2):108-16. PubMed ID: 26790362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.
    Hacein-Bey-Abina S; Pai SY; Gaspar HB; Armant M; Berry CC; Blanche S; Bleesing J; Blondeau J; de Boer H; Buckland KF; Caccavelli L; Cros G; De Oliveira S; Fernández KS; Guo D; Harris CE; Hopkins G; Lehmann LE; Lim A; London WB; van der Loo JC; Malani N; Male F; Malik P; Marinovic MA; McNicol AM; Moshous D; Neven B; Oleastro M; Picard C; Ritz J; Rivat C; Schambach A; Shaw KL; Sherman EA; Silberstein LE; Six E; Touzot F; Tsytsykova A; Xu-Bayford J; Baum C; Bushman FD; Fischer A; Kohn DB; Filipovich AH; Notarangelo LD; Cavazzana M; Williams DA; Thrasher AJ
    N Engl J Med; 2014 Oct; 371(15):1407-17. PubMed ID: 25295500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential genotoxicity from integration sites in CLAD dogs treated successfully with gammaretroviral vector-mediated gene therapy.
    Hai M; Adler RL; Bauer TR; Tuschong LM; Gu YC; Wu X; Hickstein DD
    Gene Ther; 2008 Jul; 15(14):1067-71. PubMed ID: 18369320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial.
    Wang GP; Berry CC; Malani N; Leboulch P; Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Bushman FD
    Blood; 2010 Jun; 115(22):4356-66. PubMed ID: 20228274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertional gene activation by lentiviral and gammaretroviral vectors.
    Bokhoven M; Stephen SL; Knight S; Gevers EF; Robinson IC; Takeuchi Y; Collins MK
    J Virol; 2009 Jan; 83(1):283-94. PubMed ID: 18945765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus.
    Beard BC; Keyser KA; Trobridge GD; Peterson LJ; Miller DG; Jacobs M; Kaul R; Kiem HP
    Hum Gene Ther; 2007 May; 18(5):423-34. PubMed ID: 17518616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral integration and human gene therapy.
    Bushman FD
    J Clin Invest; 2007 Aug; 117(8):2083-6. PubMed ID: 17671645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput genomic mapping of vector integration sites in gene therapy studies.
    Beard BC; Adair JE; Trobridge GD; Kiem HP
    Methods Mol Biol; 2014; 1185():321-44. PubMed ID: 25062639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency.
    Thornhill SI; Schambach A; Howe SJ; Ulaganathan M; Grassman E; Williams D; Schiedlmeier B; Sebire NJ; Gaspar HB; Kinnon C; Baum C; Thrasher AJ
    Mol Ther; 2008 Mar; 16(3):590-8. PubMed ID: 18180772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA
    Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector.
    Cornils K; Bartholomae CC; Thielecke L; Lange C; Arens A; Glauche I; Mock U; Riecken K; Gerdes S; von Kalle C; Schmidt M; Roeder I; Fehse B
    Exp Hematol; 2013 Jan; 41(1):28-38.e3. PubMed ID: 22989760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gammaretroviral vector integration occurs overwhelmingly within and near DNase hypersensitive sites.
    Liu M; Li CL; Stamatoyannopoulos G; Dorschner MO; Humbert R; Stamatoyannopoulos JA; Emery DW
    Hum Gene Ther; 2012 Feb; 23(2):231-7. PubMed ID: 21981728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retroviral vector common integration site between leupaxin and zinc finger protein 91 (ZFP91) observed in baboon hematopoietic repopulating cells.
    Kiem HP; Ironside C; Beard BC; Trobridge GD
    Exp Hematol; 2010 Sep; 38(9):819-22, 822.e1-3. PubMed ID: 20434516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodology and software to detect viral integration site hot-spots.
    Presson AP; Kim N; Xiaofei Y; Chen IS; Kim S
    BMC Bioinformatics; 2011 Sep; 12():367. PubMed ID: 21914224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.
    Gaspar HB; Cooray S; Gilmour KC; Parsley KL; Adams S; Howe SJ; Al Ghonaium A; Bayford J; Brown L; Davies EG; Kinnon C; Thrasher AJ
    Sci Transl Med; 2011 Aug; 3(97):97ra79. PubMed ID: 21865537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.
    Beard BC; Dickerson D; Beebe K; Gooch C; Fletcher J; Okbinoglu T; Miller DG; Jacobs MA; Kaul R; Kiem HP; Trobridge GD
    Mol Ther; 2007 Jul; 15(7):1356-65. PubMed ID: 17440443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.
    Greene MR; Lockey T; Mehta PK; Kim YS; Eldridge PW; Gray JT; Sorrentino BP
    Hum Gene Ther Methods; 2012 Oct; 23(5):297-308. PubMed ID: 23075105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.